Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.740
+0.040 (0.85%)
Dec 20, 2024, 4:00 PM EST - Market closed

Adverum Biotechnologies Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for ADVM stock have an average target of 27.83, with a low estimate of 10 and a high estimate of 40. The average target predicts an increase of 487.13% from the current stock price of 4.74.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $27.83 $30 $40
Change +110.97% +487.13% +532.91% +743.88%
* Price targets were last updated on Nov 19, 2024.

Analyst Ratings

The average analyst rating for ADVM stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 444444
Buy 111111
Hold 111111
Sell 000000
Strong Sell 000000
Total 666666

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +532.91% Nov 19, 2024
RBC Capital
RBC Capital
Hold
Maintains
$12$10
Hold Maintains $12$10 +110.97% Nov 5, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$60$40
Strong Buy Maintains $60$40 +743.88% Aug 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +532.91% Aug 13, 2024
RBC Capital
RBC Capital
Hold
Maintains
$15$12
Hold Maintains $15$12 +153.16% Aug 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
1.02M
from 3.60M
Decreased by -71.67%
Revenue Next Year
14.72M
from 1.02M
Increased by 1,342.84%
EPS This Year
-5.11
from -11.62
EPS Next Year
-4.77
from -5.11
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
250.00K-7.50M-3.60M1.02M14.72M460.53K
Revenue Growth
-84.49%-----71.67%1,342.84%-96.87%
EPS
-10.06-13.80-14.85-15.57-11.62-5.11-4.77-4.25
EPS Growth
--------
Forward PE
--------
No. Analysts -----10107
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 1.1M 105.0M 948,150
Avg 1.0M 14.7M 460,530
Low 980,000 n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High
-70.8%
10,194.1%
-93.6%
Avg
-71.7%
1,342.8%
-96.9%
Low
-72.8%
- -

EPS Forecast

EPS 202420252026202720282029
High -4.85 -0.22 -0.18
Avg -5.11 -4.77 -4.25
Low -5.30 -6.08 -6.42

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.